Prevalence and efficacy of stimulant drug use with mentally retarded children and youth.
Gadow
K D
KD
D000293:Adolescent; D000328:Adult; D000368:Aged; D000661:Amphetamine / Q000008:administration & dosage / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy; D002675:Child, Preschool; D003625:Data Collection; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012112:Residential Facilities; D012574:Schools; D012894:Sleep Stages / Q000187:drug effects; D013064:Speech Disorders / Q000188:drug therapy; D013239:Stereotyped Behavior / Q000187:drug effects; D013268:Stimulation, Chemical; D014481:United States
D000697:Central Nervous System Stimulants; D000661:Amphetamine